Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company also provided guidance for fiscal 2023. Adjusted earnings increased to $4.96 per share in the September quarter from $4.70 per share in the year-ago period. The reported net income was $1.73 billion or […]
“Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company also provided guidance for fiscal 2023. Adjusted earnings increased to $4.96 per share in the September quarter from $4.70 per share in the year-ago period. The reported net income was $1.73 billion or […]
· October 31, 2023
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company also provided guidance for fiscal 2023.
Adjusted earnings increased to $4.96 per share in the September quarter from $4.70 per share in the year-ago period. The reported net income was $1.73 billion or $3.22 per share in the latest quarter, compared to $2.14 billion or $3.98 per share in the same period of last year.
Total revenues increased 4% from last year to $6.9 billion during the three-month period. There was a 5% growth in product sales, benefiting from double-digit volume growth.
